Finland· FI-REL-REL860
Pertriptyl
A amitriptylin und psycholeptika product, registered in Finland by Orion Corporation Orion Pharma. The same ATC class is registered in 2 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Amitriptylin und psycholeptika is registered in 2 of 19 countries.
Countries holding a registration under ATC N06CA01 (amitriptylin und psycholeptika), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Amitriptylin und psycholeptika · ATC N06CA01
2 / 19 countries
- Finlandprice
- Switzerlandprice
The record
At a glance
Fimea (Finland)- Manufacturer
- Orion Corporation Orion Pharma
- Country
- Finland (FI)
- ATC code
- N06CA01
- ATC class
- Amitriptylin und Psycholeptika
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
7 interactions on record for amitriptylin und psycholeptika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Amitriptylin und psycholeptika · interactions on record
7 records
7 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame class
Other records under N06CA01
Amitriptylin und psycholeptika, as other registers publish it.
- FinlandKlotriptylOrion Corporation
- FinlandKlotriptyl miteOrion Corporation
- FinlandLimbitrolViatris Oy
- SwitzerlandLimbitrol, HartkapselMEDA Pharmaceuticals Switzerland GmbH
- SwitzerlandLimbitrol, HartkapselMEDA Pharmaceuticals Switzerland GmbH
- SwitzerlandLimbitrol, HartkapselMEDA Pharmaceuticals Switzerland GmbH
- FinlandPertriptylOrion Corporation
- FinlandPertriptylOrion Corporation
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/efcdb20c-b620-4e7c-8def-11395ff9a4ee GET /v1/drugs/efcdb20c-b620-4e7c-8def-11395ff9a4ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "7.5",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "ED",
"strength": "2 mg / 10 mg",
"atc_label": "amitriptyliini ja psyykenlääke",
"ma_number": "6464",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL860",
"authorised_at": "1972-10-25"
}See everything about amitriptylin und psycholeptika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.